Delivery Order SPE2DB20D3101-SPE2DB23FRCS8
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,069.87, is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used for the emergency treatment of opioid overdose. The contract has a firm fixed price pricing type and an ultimate completion date of April 4, 2024. AmerisourceBergen holds a significant Indefinite...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical opioid overdose reversal medication, with a ceiling value of $8,804.66. The contract has an ultimate completion date of April 27, 2023 and is a firm fixed-price delivery order. AmerisourceBergen holds a larger Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,486.16, is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used for the treatment of opioid overdose. The contract has a firm fixed price pricing type and an ultimate completion date of March 28, 2024. Amerisourcebergen holds a significant Indefinite Delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical opioid overdose reversal medication, with a ceiling value of $1,591.68 and a completion date of June 10, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdoses. The contract has a ceiling value of $2,501.13 and runs through March 8, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical opioid overdose reversal medication, with a ceiling value of $1,632.86 and a period of performance through March 14, 2024. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen holds a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $95,505.95, is for the delivery of 4 mg NARCAN nasal spray units. NARCAN is an opioid overdose reversal medication. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 19, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical opioid overdose reversal medication, with a potential value of $1,193.76 and a completion date of February 21, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NARCAN 4 mg nasal spray, a medication used to treat opioid overdose. The contract has a ceiling value of $1,480.05 and is set to expire on May 7, 2025. This contract is not designated as a set-aside and is awarded as a firm fixed-price delivery order. AmerisourceBergen Drug Corp...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,457.64, is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdoses. The contract is a firm-fixed-price delivery order, and does not have a set-aside designation, indicating it was awarded through open competition. AmerisourceBergen holds a larger...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB23FRCS8Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical opioid overdose reversal medication, with a ceiling value of $1,573.04 and a completion date of February 16, 2023. The contract is structured as a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order falls under the broader DLA IDC, enabling efficient government procurement of essential medical countermeasures for military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 2/15/23 |